SGK1-IN-4
CAS No. 1628048-93-0
SGK1-IN-4( —— )
Catalog No. M29000 CAS No. 1628048-93-0
SGK1-IN-4 is a selective inhibitor of SGK1 and can be used in studies about osteoarthritis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 318 | Get Quote |
|
| 5MG | 264 | Get Quote |
|
| 10MG | 376 | Get Quote |
|
| 25MG | 613 | Get Quote |
|
| 50MG | 807 | Get Quote |
|
| 100MG | 1079 | Get Quote |
|
| 200MG | 1451 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSGK1-IN-4
-
NoteResearch use only, not for human use.
-
Brief DescriptionSGK1-IN-4 is a selective inhibitor of SGK1 and can be used in studies about osteoarthritis.
-
DescriptionSGK1-IN-4 is a selective inhibitor of SGK1 and can be used in studies about osteoarthritis.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1628048-93-0
-
Formula Weight517.96
-
Molecular FormulaC23H21ClFN5O4S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (482.66 mM)
-
SMILESO(C1=C2C(=NC(=N1)C3=CC=C(NS(=O)(=O)C4=C(F)C=CC(Cl)=C4)C=C3)NN=C2)[C@@H]5CC[C@@H](O)CC5
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
L-Argininamide dihyd...
L-Argininamide (L-Arm) is used as a model compound in studies of the physicochemical characteristic of ligand binding DNA aptamers and their potential development as fluorescent aptasensors.
-
Dimethylmatairesinol
Dimethylmatairesinol (compound 8) is a lignan compound isolated from the seed of Hernandia nymphaeifolia. Dimethylmatairesinol shows cytotoxicity against the KKU-M156 and HepG2 cell line with IC50s of 5.4 μM (Emax 59%) and 5.2 μM (Emax 78%), respectively.
-
PRX-08066 Maleic aci...
PRX-08066 Maleic acid is a selective 5-HT2B receptor antagonist with IC50 of 3.4 nM, prevents the severity of pulmonary arterial hypertension in the MCT rat model. Phase 2.
Cart
sales@molnova.com